logo

For the Inventor, By the Inventor

Telangana, India

Hetero Labs Limited


USPTO Granted Patents = 15



Forward Citations = 15

Loading Chart...
Loading Chart...

35 inventors (with patents filed for the assignee):

goldMedal Parthasaradhi Reddy Bandi (8 out of 8 patents)

silverMedal Kura Rathnakar Reddy (7 out of 94 patents)

bronzeMedal Bandi Parthasaradhi Reddy (6 out of 96 patents)

4.  Panduranga Reddy Adulla (5 out of 5 patents)

5.  Rathnakar Reddy Kura (5 out of 5 patents)

6.  Bandi Vamsi Krishna (4 out of 42 patents)

7.  Khadgapathi Podile (3 out of 3 patents)

8.  Sunil Deviprasad Tiwari (3 out of 3 patents)

9.  David Krupadanam Gazula Levi (3 out of 3 patents)

10.  Theodore John Nitz (3 out of 45 patents)

11.  Carl Thomas Wild (3 out of 19 patents)

12.  David Eugene Martin (3 out of 4 patents)

13.  Bhaskar Reddy Kasireddy (3 out of 3 patents)

14.  Prakash Shetiya (2 out of 2 patents)

15.  Adulla Panduranga Reddy (2 out of 2 patents)


15 patents:

1. 12378281 - Triterpenone derivatives as HIV inhibitors (2025-08-05),
2. 12275712 - Triterpene derivatives as HIV inhibitors (2025-04-14),
3. 11655220 - Process for the preparation of angiotensin II receptor blockers (2023-05-23),
4. 11471447 - Stable pharmaceutical product and vessel comprising sodium picosulfate, magnesium oxide and citric acid (2022-10-18),
5. 11045423 - Anti-retroviral compositions (2021-06-29),
6. 11034718 - C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors (2021-06-15),
7. 11020351 - Stable bilayer tablet compositions (2021-06-01),
8. 10822314 - Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound (2020-11-03),
9. 10669305 - C-3 novel triterpenone with C-28 urea derivatives as HIV inhibitors (2020-06-02),
10. 10562867 - Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound (2020-02-18),
11. 10533035 - C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors (2020-01-14),
12. 10370405 - C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitors (2019-08-06),
13. 10329281 - Polymorphs and process for the preparation of quinazolinyl derivatives (2019-06-25),
14. 10214497 - Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound (2019-02-26),
15. 9868758 - Betulinic proline imidazole derivatives as HIV inhibitors (2018-01-16),
Hetero Labs Limited is one of India's leading generic pharmaceutical companies. Established in 1993, Hetero Labs has become a global player with a wide range of products and services in various therapeutic segments. They focus on providing affordable and high-quality medicines to patients worldwide. With state-of-the-art manufacturing facilities and a strong commitment to research and development, Hetero Labs continuously strives to improve healthcare outcomes and enhance access to affordable medicines.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

15 Patents

#2 in Telangana

#122 in India

#38,669 in the World

...
Telangana, India

Hetero Labs Limited

Forward Citations = 15

35 inventors:

goldMedal Parthasaradhi Reddy Bandi (8 out of 8 patents)

silverMedal Kura Rathnakar Reddy (7 out of 94 patents)

bronzeMedal Bandi Parthasaradhi Reddy (6 out of 96 patents)

4.  Panduranga Reddy Adulla (5 out of 5 patents)

5.  Rathnakar Reddy Kura (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com
Loading…